Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/04/20
End: 07/08/21
Due: 07/08/22
Phase: N/A
Priority: Normal
Start: 01/07/25
End: 11/28/25
Due: 11/28/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study to Determine the Safety of AV-1, an Antibody Being Developed for Treatment of Dengue, in Healthy Volunteers | NCT04273217 | AbViro LLC | user2@example.com | None | 2020-02-04 | 2021-07-08 | 2022-07-08 | - | - | 2025-07-14 |
| A Study to Evaluate the Safety and Efficacy of AV-1 Against Dengue Virus 3 (DENV-3) Infection | NCT06799741 | AbViro LLC | user2@example.com | None | 2025-01-07 | 2025-11-28 | 2026-11-28 | - | - | 2025-07-14 |